Growing Up with Liver Disease


Barrier to adherence

Strategies

Naive about the risks of non-adherence

Individualized education about illness and medication

Burden of medication regime: too many tablets or too many times a day

Simplify medication regimes

Ensure young person understands rationale for each medication and anticipated course

Non-intentional non-adherence: forgetting or organizational difficulties

Pill boxes, blister packs

Medication charts and apps

Alarm reminders

Visual reminders

Intentional non-adherence: not taking medication due to the meaning of it/psychological benefits of non-adherence

Explore beliefs about illness and medication, including the benefits of non-adherence for the young person.

Referral to psychologist

Intentional adherence: practical barriers

Assess barriers such as housing, finances, parental support

Referral to social worker



Non-adherence has also been found to be associated with psychosocial distress, such as PTSD [45] and other psychosocial stressors [53]. Social difficulties such as financial restrictions should not be overlooked. For example, in the UK at the age of 18 years, young people have to start paying for their prescriptions and travel to hospital; when money is limited, these can be very real barriers to adherence for which support is available. Within our service, we adopt a multidisciplinary approach to identifying and managing adherence, which begins with a stance of assumed non-adherence and reinforcing disclosures; as rates are known to be around 50 %, we normalize that most young people will struggle to take all of their medication all of their time. See Table 74.2 for details of our approach for routinely assessing in this age group. From conducting a case-note review of the more complex cases seen by our clinical psychologist and specialist social worker, we found that a significant minority had entrenched relational difficulties and had experienced childhood abuse [54]. We hypothesized that non-adherence can be related to attachment difficulties and in some cases can require long-term specialist input to treat. Effective identification of non-adherence and the factors contributing to it are essential to ensure access to the appropriate services.


Table 74.2
Routine assessment and management of adherence




















































Task

Rationale

Example questions

Engage the young person

Young people are more likely to be actively involved in their health care and more adherent if they have a good relationship with their health-care provider

See HEADSS [33]: ask about home, school/college, friendships, activities and interests

Screen for psychosocial difficulties

Gather information about how the illness and treatment fits into the young person’s life

Assess who is responsible for medication

Responsibility needs to be handed over from parents to young person: difficulties often arise during this transition

‘Who is in charge of medication at home?

How long have you been taking charge of your medication?

Who organizes the prescriptions?’

Assume non-adherence and routinely assess with every patient in a non-judgemental manner

Rates of non-adherence exceed 50 %—most young people will be non-adherent some of the time

‘In a normal week, how often do you tend to miss your medication?

How often do you take it at a different time?’

Impossible to predict who will be non-adherent so need to ask everyone

Asking questions in a non-judgemental way that assumed some non-adherence is more likely to increase disclosure

Normalize: full adherence is difficult; very few people are adherent all of the time

More likely to increase honest disclosure and willingness to discuss the barriers to their adherence

‘Most young people we see struggle to take all of their medication all of the time.

We know that it can be a really hard thing to have to take medication every day.’

Trying to scare or tell off your patient is unlikely to improve their adherence, but will ensure that they do not disclose it to you again!

Check understanding of illness and risks of non-adherence

Knowledge is necessary (but not sufficient) for adherence

‘How would you explain your condition to someone who hadn’t heard of it before?

What do you think the medications do? What do you think would happen if you didn’t take your medication?

How many doses of medication do you think you could get away without taking?’

Need to ensure that the young person understands why they need to take medication and fully understand the risks of not taking it

Assess intentionality of non-adherence

Different determinants of non-adherence require different interventions

‘Are there times that you remember your medication, but choose not to take it for some other reason?

How often do you forget your medication compared to choosing not to take it?

When you miss it, do you always miss all of your medication or just some of them?’

Identify barriers

Different determinants of non-adherence require different interventions

‘What gets in the way of taking medication?

What is the worst/hardest thing about (having to take) medication?’


HEADSS home, education/employment, peer group activities, drugs, sexuality, and suicide/depression

Non-adherence is thought to be related to both the adolescent stage of development (e.g. [17]) and the process of transitioning into adult services at this risky period (e.g. [53]). It is therefore crucial for every centre to carefully consider how to transition their young people. This is reviewed below.



Transition from Pediatric to Adult-Centred Health Services


The adolescent health society defined transition in 1993 as a ‘Purposeful, planned process that addresses the medical, psychosocial and educational/vocational needs of adolescents and young adults with chronic physical and medical conditions from child-centred to adult-orientated healthcare systems’.

In 2002, American Academy of Pediatrics published the following consensus: ‘The goal of transition in health care for young adults with special health care needs is to maximize lifelong functioning and potential through the provision of high-quality developmentally appropriate health care services that continue uninterrupted as the individual moves from adolescence to adulthood’ [55]. Several reports, mainly in the transplant setting, have since been published, with worse outcomes for patients transplanted during adolescence but a decrease in 1 year mortality in renal transplant recipients as patients age from 20 to 30 years. This supports the concept that maturation and complete development occur after the age of 18 years [9]. It seems that to date the development of dedicated programs to optimize transition from pediatric to adult-centred care has mainly been driven by pediatric specialists, with currently no consensus as to how to implement or measure this, or even define what a successful outcome is. Different models of transition programs have been described and will need to be developed depending on the set up and needs of the individual centres. Pediatric teams should focus on developing strategies to overcome barriers to an adequate transition including learning difficulties, social factors, patients in care and patients with mental health problems and aim for an integrative process. With regards to congenital and rare conditions typically presenting in childhood, where adult teams might be less familiar in managing these conditions, management in specialized centres with pediatric expertize is recommended. In cardiology, for example, it is recommended for ‘grown up adults with congenital heart disease’ also known as GUCH to be followed up in specialized centres with multidisciplinary input [56].

Patients and their families should be given realistic expectations of the adult health-care systems where the patient is expected to advocate for themselves and therefore self-management skills should be included in the transition process.

Experience in the renal transplant setting demonstrated that the introduction of an integrated pediatric/young adult joint transition clinic and care pathway improved outcome over a 4-year period, with no episodes of late acute rejection or graft loss compared to 35 % graft loss in a group of patients who did not benefit from this service [28]. A transition service should aim to manage young people with a chronic condition in a comprehensive and holistic way and should include parents/caregivers whose role will change during the process as one of the main aspects of transition is shifting from caregiver-provided to parent-provided care and the self-management of one’s own illness [57]. It has been shown that incorporation and promotion of disease self-management within chronic care models have improved outcomes in conditions as asthma, diabetes mellitus and rheumatoid arthritis [58]. In this respect, it is important to use transition readiness tools to define a patient’s individual needs and for a multi-professional team to address these.

A recent small pilot study in a group of 20 liver transplant recipients whose care was coordinated by a transition coordinator showed, compared to a historic group of 14 patients, improved adherence to treatment during the year before transfer to adult services. After transfer, tacrolimus standard deviation (SD) scores remained stable in the group supported by the transition coordinator compared to the historic group where the tacrolimus SD increased, suggesting poorer adherence [59].

Ideally, the timing of the transition process should be flexible and aimed at the patient’s needs and readiness; however, in practice, lack of age-appropriate inpatient facilities or pediatric and adult setting being on different sites often means that patients over 18 years cannot be admitted to pediatric inpatient facilities, raising the importance of starting the transition process early enough. This is particularly relevant in patients with special health-care needs where the transition process becomes more complicated as the patient might not be able to advocate for their care, consent for procedures and manage an inpatient stay on an adult ward independently. In these cases, the multi-professional team should ensure a well-documented care; pathway is discussed prior to transition to adult services [60, 61].


Summary and Conclusions






  • With advances in medicine, more patients with liver conditions are growing in to adulthood.


  • Adolescence is a period of biological, psychological and social changes and the impact of a chronic condition on this process can be significant.


  • Outcome data suggest that young people are a unique and vulnerable cohort who deserves special attention by health professionals, focusing on better outcome and survival.


  • Growth failure and pubertal delay are prevalent and sexual health advice should be offered standard during the consultation with the young person.


  • Psychological aspects of growing up with liver disease are increasingly being recognized and identified and require management by specialized health-care professionals.
    < div class='tao-gold-member'>

    Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 12, 2016 | Posted by in HEPATOPANCREATOBILIARY | Comments Off on Growing Up with Liver Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access